

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.33962135 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.30962966 |
| 3 | positive thymic T cell selection (GO:0045059) | 5.22588805 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.89103592 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.89103592 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.76032050 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.51779794 |
| 8 | positive T cell selection (GO:0043368) | 4.32296582 |
| 9 | thymic T cell selection (GO:0045061) | 4.31255064 |
| 10 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.25726807 |
| 11 | positive regulation of histone deacetylation (GO:0031065) | 4.24077510 |
| 12 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 4.15994244 |
| 13 | T cell selection (GO:0045058) | 3.97690255 |
| 14 | tolerance induction (GO:0002507) | 3.81180315 |
| 15 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.76281736 |
| 16 | embryonic process involved in female pregnancy (GO:0060136) | 3.69122552 |
| 17 | negative thymic T cell selection (GO:0045060) | 3.67136042 |
| 18 | negative T cell selection (GO:0043383) | 3.65706232 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.56132092 |
| 20 | nuclear pore complex assembly (GO:0051292) | 3.47979970 |
| 21 | histone H3-K36 demethylation (GO:0070544) | 3.43740787 |
| 22 | response to interleukin-15 (GO:0070672) | 3.42092553 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 3.40709253 |
| 24 | response to laminar fluid shear stress (GO:0034616) | 3.40139634 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34944264 |
| 26 | leukocyte aggregation (GO:0070486) | 3.33782783 |
| 27 | T cell migration (GO:0072678) | 3.30847334 |
| 28 | natural killer cell differentiation (GO:0001779) | 3.30216453 |
| 29 | positive regulation of B cell differentiation (GO:0045579) | 3.25694019 |
| 30 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.21677047 |
| 31 | protein localization to endosome (GO:0036010) | 3.13741920 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.12394754 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.12394754 |
| 34 | membrane protein intracellular domain proteolysis (GO:0031293) | 3.08348117 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01516992 |
| 36 | modulation by symbiont of host immune response (GO:0052553) | 3.01516992 |
| 37 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01516992 |
| 38 | modulation by symbiont of host defense response (GO:0052031) | 3.01516992 |
| 39 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01516992 |
| 40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01516992 |
| 41 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.99312516 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95411376 |
| 43 | regulation of B cell differentiation (GO:0045577) | 2.94276683 |
| 44 | definitive hemopoiesis (GO:0060216) | 2.94158929 |
| 45 | B cell receptor signaling pathway (GO:0050853) | 2.89781687 |
| 46 | positive regulation of interleukin-2 production (GO:0032743) | 2.88475480 |
| 47 | positive regulation of protein deacetylation (GO:0090312) | 2.86982427 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.83847656 |
| 49 | regulation of T cell tolerance induction (GO:0002664) | 2.83459607 |
| 50 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.82969361 |
| 51 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80751030 |
| 52 | myeloid dendritic cell differentiation (GO:0043011) | 2.78302331 |
| 53 | modulation by symbiont of host cellular process (GO:0044068) | 2.78007105 |
| 54 | dosage compensation (GO:0007549) | 2.77932571 |
| 55 | endothelial cell chemotaxis (GO:0035767) | 2.77312692 |
| 56 | hepatocyte apoptotic process (GO:0097284) | 2.73773595 |
| 57 | T cell receptor signaling pathway (GO:0050852) | 2.72085172 |
| 58 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.71668113 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 2.69221180 |
| 60 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68970256 |
| 61 | response to muramyl dipeptide (GO:0032495) | 2.68517571 |
| 62 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.67389453 |
| 63 | T-helper cell differentiation (GO:0042093) | 2.67389453 |
| 64 | B cell homeostasis (GO:0001782) | 2.65481877 |
| 65 | T cell costimulation (GO:0031295) | 2.63469548 |
| 66 | positive regulation of isotype switching (GO:0045830) | 2.62766847 |
| 67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.62548098 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60887080 |
| 69 | skeletal muscle adaptation (GO:0043501) | 2.59825649 |
| 70 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.57537688 |
| 71 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.57369714 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.57369714 |
| 73 | viral transcription (GO:0019083) | 2.56926256 |
| 74 | striated muscle atrophy (GO:0014891) | 2.55324119 |
| 75 | positive regulation of Rap GTPase activity (GO:0032854) | 2.55191127 |
| 76 | positive regulation of myotube differentiation (GO:0010831) | 2.54970919 |
| 77 | lymphocyte costimulation (GO:0031294) | 2.54658152 |
| 78 | myeloid dendritic cell activation (GO:0001773) | 2.54210767 |
| 79 | nuclear pore organization (GO:0006999) | 2.52255642 |
| 80 | pore complex assembly (GO:0046931) | 2.52125792 |
| 81 | mRNA transcription (GO:0009299) | 2.51342387 |
| 82 | mature B cell differentiation involved in immune response (GO:0002313) | 2.50754725 |
| 83 | JAK-STAT cascade (GO:0007259) | 2.49488048 |
| 84 | apoptotic process involved in morphogenesis (GO:0060561) | 2.47380363 |
| 85 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.46844022 |
| 86 | cortical actin cytoskeleton organization (GO:0030866) | 2.46561978 |
| 87 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.46313417 |
| 88 | mature B cell differentiation (GO:0002335) | 2.45464508 |
| 89 | modulation by virus of host process (GO:0019054) | 2.45177691 |
| 90 | negative regulation of heart growth (GO:0061117) | 2.44188869 |
| 91 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.44188869 |
| 92 | regulation of extracellular matrix disassembly (GO:0010715) | 2.43650598 |
| 93 | cellular extravasation (GO:0045123) | 2.43305482 |
| 94 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.42863325 |
| 95 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.41258572 |
| 96 | macrophage activation involved in immune response (GO:0002281) | 2.40905969 |
| 97 | Rap protein signal transduction (GO:0032486) | 2.40555338 |
| 98 | regulation of natural killer cell differentiation (GO:0032823) | 2.39956460 |
| 99 | peptidyl-threonine phosphorylation (GO:0018107) | 2.38990057 |
| 100 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.38963615 |
| 101 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.38754706 |
| 102 | regulation of RNA export from nucleus (GO:0046831) | 2.38138867 |
| 103 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.36698602 |
| 104 | response to peptidoglycan (GO:0032494) | 2.36554723 |
| 105 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.36024140 |
| 106 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.35403447 |
| 107 | T cell homeostasis (GO:0043029) | 2.34910097 |
| 108 | peptidyl-lysine dimethylation (GO:0018027) | 2.34833123 |
| 109 | regulation of cholesterol homeostasis (GO:2000188) | 2.34474241 |
| 110 | regulation of histone deacetylation (GO:0031063) | 2.34103537 |
| 111 | peptidyl-threonine modification (GO:0018210) | 2.33914032 |
| 112 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.33693589 |
| 113 | cellular response to ethanol (GO:0071361) | 2.32173726 |
| 114 | translational termination (GO:0006415) | 2.31738460 |
| 115 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.30548901 |
| 116 | lymph node development (GO:0048535) | 2.29718567 |
| 117 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.29698130 |
| 118 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.28866431 |
| 119 | regulation of necroptotic process (GO:0060544) | 2.28641679 |
| 120 | gland morphogenesis (GO:0022612) | 2.28538484 |
| 121 | alpha-beta T cell activation (GO:0046631) | 2.28298384 |
| 122 | germinal center formation (GO:0002467) | 2.28295392 |
| 123 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.28262140 |
| 124 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.28256641 |
| 125 | activation of JUN kinase activity (GO:0007257) | 2.27964168 |
| 126 | lymphocyte homeostasis (GO:0002260) | 2.27917059 |
| 127 | positive regulation of interferon-alpha production (GO:0032727) | 2.27518338 |
| 128 | skin morphogenesis (GO:0043589) | 2.27382197 |
| 129 | interferon-gamma production (GO:0032609) | 2.27332129 |
| 130 | natural killer cell activation (GO:0030101) | 2.27295906 |
| 131 | cellular response to interleukin-15 (GO:0071350) | 2.27215028 |
| 132 | leukocyte cell-cell adhesion (GO:0007159) | 2.26589625 |
| 133 | muscle atrophy (GO:0014889) | 2.26309086 |
| 134 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.25537908 |
| 135 | Peyers patch development (GO:0048541) | 2.25537908 |
| 136 | negative regulation of T cell mediated immunity (GO:0002710) | 2.25149343 |
| 137 | membrane protein ectodomain proteolysis (GO:0006509) | 2.24555761 |
| 138 | energy homeostasis (GO:0097009) | 2.24431041 |
| 139 | mannose metabolic process (GO:0006013) | 2.23485085 |
| 140 | hypotonic response (GO:0006971) | 2.23480699 |
| 141 | cellular response to epinephrine stimulus (GO:0071872) | 2.23467292 |
| 142 | response to fluid shear stress (GO:0034405) | 2.22389500 |
| 143 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.22194374 |
| 144 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.22167870 |
| 145 | cellular response to fluid shear stress (GO:0071498) | 2.21886790 |
| 146 | negative regulation of type 2 immune response (GO:0002829) | 2.21883047 |
| 147 | type I interferon signaling pathway (GO:0060337) | 2.21475652 |
| 148 | cellular response to type I interferon (GO:0071357) | 2.21475652 |
| 149 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.21439842 |
| 150 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.20482883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.83836872 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.77489876 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.69026510 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.65938441 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.31250980 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.99608401 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.94340557 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.82622449 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.80715979 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.76260983 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.68469551 |
| 12 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.57634816 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.51069287 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.46788266 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.40690019 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36189713 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.29431980 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24397189 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.23553584 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23334741 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23014852 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.22999141 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.21532714 |
| 24 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.11069109 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08598262 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06255425 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00798249 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.93475937 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93457999 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92791302 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.92097253 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91801310 |
| 33 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.89915747 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.89136868 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86675288 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.86227781 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.84791936 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.81355439 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80096819 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78363661 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.78237226 |
| 42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77788379 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77334502 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.76090875 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74453855 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74346066 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.64555869 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62879044 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62474495 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62059133 |
| 51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.59040417 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58291635 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57640858 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56973350 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50204748 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50129520 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49058852 |
| 58 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47533767 |
| 59 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46388132 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46245247 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45912033 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.44871707 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41324314 |
| 64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.38790405 |
| 65 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37301916 |
| 66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37301916 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37129833 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36220012 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31828232 |
| 70 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.31203288 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31165879 |
| 72 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29151944 |
| 73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28105582 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27527381 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26441955 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25333139 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24904846 |
| 78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23953123 |
| 79 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23735845 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20444940 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19140827 |
| 82 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19100307 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18609256 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18248712 |
| 85 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.16379519 |
| 86 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16354303 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13620415 |
| 88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13301082 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13013600 |
| 90 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12417942 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11241717 |
| 92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08856231 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08707189 |
| 94 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08159870 |
| 95 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07651935 |
| 96 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07468689 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06359813 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05138618 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03551258 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02848510 |
| 101 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02478211 |
| 102 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01968905 |
| 103 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01946925 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00679626 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00345124 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99649706 |
| 107 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99181806 |
| 108 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98496943 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98252572 |
| 110 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98081967 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97574560 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97349059 |
| 113 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.96420407 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95917479 |
| 115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95856044 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95553799 |
| 117 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95540039 |
| 118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95232621 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94109859 |
| 120 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93522137 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91872326 |
| 122 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91593172 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90835720 |
| 124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90835720 |
| 125 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90627595 |
| 126 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90345875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.32602264 |
| 2 | MP0004510_myositis | 3.25769094 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.25653950 |
| 4 | MP0002009_preneoplasia | 3.04750354 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 3.00803913 |
| 6 | MP0000685_abnormal_immune_system | 2.95838565 |
| 7 | MP0005387_immune_system_phenotype | 2.87807795 |
| 8 | MP0001790_abnormal_immune_system | 2.87807795 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.80268563 |
| 10 | MP0003436_decreased_susceptibility_to | 2.67723157 |
| 11 | MP0001800_abnormal_humoral_immune | 2.57712848 |
| 12 | MP0005076_abnormal_cell_differentiation | 2.56156832 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.48785296 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.46899643 |
| 15 | MP0004947_skin_inflammation | 2.35099425 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.24268759 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.18746921 |
| 18 | MP0002723_abnormal_immune_serum | 2.09387544 |
| 19 | MP0008961_abnormal_basal_metabolism | 2.07308340 |
| 20 | MP0002405_respiratory_system_inflammati | 2.05882043 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 2.05008735 |
| 22 | MP0008057_abnormal_DNA_replication | 2.02051077 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.94347108 |
| 24 | MP0001819_abnormal_immune_cell | 1.91935031 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.88504577 |
| 26 | MP0002398_abnormal_bone_marrow | 1.86440268 |
| 27 | MP0008260_abnormal_autophagy | 1.85950851 |
| 28 | MP0005671_abnormal_response_to | 1.84945364 |
| 29 | MP0009840_abnormal_foam_cell | 1.80624286 |
| 30 | MP0009278_abnormal_bone_marrow | 1.79492637 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.78117178 |
| 32 | MP0004130_abnormal_muscle_cell | 1.77930411 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.77770046 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.71174864 |
| 35 | MP0003866_abnormal_defecation | 1.69281641 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.68468730 |
| 37 | MP0003646_muscle_fatigue | 1.68079105 |
| 38 | MP0005025_abnormal_response_to | 1.67788794 |
| 39 | MP0000716_abnormal_immune_system | 1.64267984 |
| 40 | MP0001873_stomach_inflammation | 1.63678122 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.62154785 |
| 42 | MP0002419_abnormal_innate_immunity | 1.61765171 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.60124060 |
| 44 | MP0005451_abnormal_body_composition | 1.57612962 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.56616042 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.55158516 |
| 47 | MP0006082_CNS_inflammation | 1.51044250 |
| 48 | MP0003091_abnormal_cell_migration | 1.50664577 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.50366387 |
| 50 | MP0002722_abnormal_immune_system | 1.50148967 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.49916357 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.49598915 |
| 53 | MP0004036_abnormal_muscle_relaxation | 1.45809171 |
| 54 | MP0003045_fibrosis | 1.44130385 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.42631786 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.42311209 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.34927032 |
| 58 | MP0002429_abnormal_blood_cell | 1.34910691 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.34350665 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.32355195 |
| 61 | MP0002933_joint_inflammation | 1.26768904 |
| 62 | MP0000733_abnormal_muscle_development | 1.26693695 |
| 63 | MP0005023_abnormal_wound_healing | 1.26125275 |
| 64 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22910272 |
| 65 | MP0004233_abnormal_muscle_weight | 1.17228025 |
| 66 | MP0009785_altered_susceptibility_to | 1.16388371 |
| 67 | MP0002796_impaired_skin_barrier | 1.16125676 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.15940668 |
| 69 | MP0002006_tumorigenesis | 1.15903457 |
| 70 | MP0003172_abnormal_lysosome_physiology | 1.14863232 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.13204510 |
| 72 | MP0000759_abnormal_skeletal_muscle | 1.10239549 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.10039483 |
| 74 | MP0003828_pulmonary_edema | 1.09523841 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.08424506 |
| 76 | MP0004484_altered_response_of | 1.08397036 |
| 77 | MP0000750_abnormal_muscle_regeneration | 1.07857535 |
| 78 | MP0003279_aneurysm | 1.05377594 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 1.05150253 |
| 80 | MP0001545_abnormal_hematopoietic_system | 1.05150253 |
| 81 | MP0000015_abnormal_ear_pigmentation | 1.05049500 |
| 82 | MP0001853_heart_inflammation | 1.04651781 |
| 83 | MP0000490_abnormal_crypts_of | 1.03314338 |
| 84 | MP0001216_abnormal_epidermal_layer | 1.00878255 |
| 85 | MP0005310_abnormal_salivary_gland | 0.99839194 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.97872282 |
| 87 | MP0001849_ear_inflammation | 0.97777818 |
| 88 | MP0003724_increased_susceptibility_to | 0.97480336 |
| 89 | MP0003448_altered_tumor_morphology | 0.97033237 |
| 90 | MP0003868_abnormal_feces_composition | 0.96824100 |
| 91 | MP0000751_myopathy | 0.96033154 |
| 92 | MP0000003_abnormal_adipose_tissue | 0.95898183 |
| 93 | MP0001661_extended_life_span | 0.95208720 |
| 94 | MP0002060_abnormal_skin_morphology | 0.94635876 |
| 95 | MP0004381_abnormal_hair_follicle | 0.93632577 |
| 96 | MP0010630_abnormal_cardiac_muscle | 0.93054540 |
| 97 | MP0002106_abnormal_muscle_physiology | 0.92074050 |
| 98 | MP0005621_abnormal_cell_physiology | 0.90218995 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.88336271 |
| 100 | MP0001851_eye_inflammation | 0.88132999 |
| 101 | MP0000747_muscle_weakness | 0.85748726 |
| 102 | MP0000858_altered_metastatic_potential | 0.83631016 |
| 103 | MP0008438_abnormal_cutaneous_collagen | 0.83169053 |
| 104 | MP0009931_abnormal_skin_appearance | 0.82458466 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.81338669 |
| 106 | MP0008469_abnormal_protein_level | 0.80866804 |
| 107 | MP0002254_reproductive_system_inflammat | 0.80411152 |
| 108 | MP0010368_abnormal_lymphatic_system | 0.78240389 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.76874411 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.76871143 |
| 111 | MP0002971_abnormal_brown_adipose | 0.75732427 |
| 112 | MP0000609_abnormal_liver_physiology | 0.75269588 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.74428084 |
| 114 | MP0005501_abnormal_skin_physiology | 0.73710495 |
| 115 | MP0005390_skeleton_phenotype | 0.73087120 |
| 116 | MP0000604_amyloidosis | 0.70840453 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.68535762 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.68465437 |
| 119 | MP0000377_abnormal_hair_follicle | 0.68324498 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.68173224 |
| 121 | MP0002925_abnormal_cardiovascular_devel | 0.66091381 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.64149192 |
| 123 | MP0001784_abnormal_fluid_regulation | 0.62354601 |
| 124 | MP0004087_abnormal_muscle_fiber | 0.62225489 |
| 125 | MP0001915_intracranial_hemorrhage | 0.61285913 |
| 126 | MP0008770_decreased_survivor_rate | 0.60699175 |
| 127 | MP0005083_abnormal_biliary_tract | 0.60335894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.37631835 |
| 2 | Nemaline bodies (HP:0003798) | 3.60901980 |
| 3 | Abnormality of the fingertips (HP:0001211) | 3.53336531 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 3.45541505 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.41559301 |
| 6 | Spinal cord lesions (HP:0100561) | 3.41471988 |
| 7 | Syringomyelia (HP:0003396) | 3.41471988 |
| 8 | Pustule (HP:0200039) | 3.41023250 |
| 9 | Cellulitis (HP:0100658) | 3.38985854 |
| 10 | Cerebral aneurysm (HP:0004944) | 3.38640984 |
| 11 | Recurrent viral infections (HP:0004429) | 3.30006951 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.20274710 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.18423302 |
| 14 | Exercise-induced myalgia (HP:0003738) | 3.15985810 |
| 15 | Increased density of long bones (HP:0006392) | 3.05400575 |
| 16 | Chronic otitis media (HP:0000389) | 2.92821041 |
| 17 | Nasal polyposis (HP:0100582) | 2.92662071 |
| 18 | Inflammation of the large intestine (HP:0002037) | 2.92203970 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 2.92030908 |
| 20 | Colitis (HP:0002583) | 2.90043662 |
| 21 | Spontaneous hematomas (HP:0007420) | 2.88043745 |
| 22 | IgM deficiency (HP:0002850) | 2.83276833 |
| 23 | Recurrent abscess formation (HP:0002722) | 2.76425734 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 2.75872003 |
| 25 | Verrucae (HP:0200043) | 2.72728823 |
| 26 | Papilloma (HP:0012740) | 2.72728823 |
| 27 | Subacute progressive viral hepatitis (HP:0006572) | 2.71376642 |
| 28 | Increased IgE level (HP:0003212) | 2.71249202 |
| 29 | T lymphocytopenia (HP:0005403) | 2.70781074 |
| 30 | Disproportionate tall stature (HP:0001519) | 2.70422191 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.68964930 |
| 32 | Stomatitis (HP:0010280) | 2.68723708 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 2.68002348 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 2.54581678 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 2.52431106 |
| 36 | Myocardial infarction (HP:0001658) | 2.52237757 |
| 37 | Abnormality of T cell number (HP:0011839) | 2.51256958 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50166377 |
| 39 | Subaortic stenosis (HP:0001682) | 2.50109880 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.50109880 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 2.50052208 |
| 42 | Type 1 muscle fiber predominance (HP:0003803) | 2.49470634 |
| 43 | Difficulty running (HP:0009046) | 2.46227780 |
| 44 | Persistence of primary teeth (HP:0006335) | 2.45745685 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.41820854 |
| 46 | Broad face (HP:0000283) | 2.40144672 |
| 47 | EMG: myopathic abnormalities (HP:0003458) | 2.39822483 |
| 48 | Asymmetry of the thorax (HP:0001555) | 2.36814755 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.35766679 |
| 50 | Emphysema (HP:0002097) | 2.30152513 |
| 51 | Shallow orbits (HP:0000586) | 2.28476732 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.27579048 |
| 53 | Spondylolisthesis (HP:0003302) | 2.27161802 |
| 54 | Sparse lateral eyebrow (HP:0005338) | 2.26846065 |
| 55 | Dislocated radial head (HP:0003083) | 2.26718888 |
| 56 | Round ear (HP:0100830) | 2.26481434 |
| 57 | Mitral valve prolapse (HP:0001634) | 2.25198459 |
| 58 | Ragged-red muscle fibers (HP:0003200) | 2.24869935 |
| 59 | Viral hepatitis (HP:0006562) | 2.24065994 |
| 60 | Abnormal platelet volume (HP:0011876) | 2.22673303 |
| 61 | Thick nail (HP:0001805) | 2.15833374 |
| 62 | Recurrent skin infections (HP:0001581) | 2.14451988 |
| 63 | Ulnar deviation of the wrist (HP:0003049) | 2.13417830 |
| 64 | Slow saccadic eye movements (HP:0000514) | 2.13275349 |
| 65 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.12603008 |
| 66 | Hematochezia (HP:0002573) | 2.12523393 |
| 67 | Ulnar bowing (HP:0003031) | 2.10673115 |
| 68 | Long eyelashes (HP:0000527) | 2.10245815 |
| 69 | Leukocytosis (HP:0001974) | 2.09161470 |
| 70 | Distal upper limb amyotrophy (HP:0007149) | 2.07381722 |
| 71 | Upper limb amyotrophy (HP:0009129) | 2.07381722 |
| 72 | Abnormality of the radial head (HP:0003995) | 2.06982695 |
| 73 | Myositis (HP:0100614) | 2.06351434 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.05997946 |
| 75 | Fatigue (HP:0012378) | 2.04417502 |
| 76 | Abnormality of T cells (HP:0002843) | 2.04031252 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03959112 |
| 78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03959112 |
| 79 | Vasculitis (HP:0002633) | 2.03897677 |
| 80 | Severe combined immunodeficiency (HP:0004430) | 2.03383410 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 2.03271797 |
| 82 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.01010016 |
| 83 | Urethral obstruction (HP:0000796) | 2.00984247 |
| 84 | Axonal loss (HP:0003447) | 2.00469638 |
| 85 | Agammaglobulinemia (HP:0004432) | 2.00031439 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 1.99723079 |
| 87 | Distal lower limb muscle weakness (HP:0009053) | 1.97983479 |
| 88 | Chest pain (HP:0100749) | 1.97700711 |
| 89 | Frequent falls (HP:0002359) | 1.97495386 |
| 90 | Meningitis (HP:0001287) | 1.97084881 |
| 91 | Increased variability in muscle fiber diameter (HP:0003557) | 1.96546723 |
| 92 | Aortic aneurysm (HP:0004942) | 1.96538097 |
| 93 | Dilatation of the ascending aorta (HP:0005111) | 1.96518296 |
| 94 | Thyroiditis (HP:0100646) | 1.95831769 |
| 95 | Aneurysm (HP:0002617) | 1.95685981 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94994836 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94994836 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94994836 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 1.94150641 |
| 100 | Macroorchidism (HP:0000053) | 1.93867374 |
| 101 | Peritonitis (HP:0002586) | 1.92752360 |
| 102 | Lower limb amyotrophy (HP:0007210) | 1.91832887 |
| 103 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.89554930 |
| 104 | Vertebral arch anomaly (HP:0008438) | 1.88365254 |
| 105 | Mitral stenosis (HP:0001718) | 1.88189552 |
| 106 | Increased mean platelet volume (HP:0011877) | 1.87720032 |
| 107 | Increased CSF protein (HP:0002922) | 1.87465368 |
| 108 | Eosinophilia (HP:0001880) | 1.87267329 |
| 109 | Thoracic kyphosis (HP:0002942) | 1.85281882 |
| 110 | Abnormality of the thoracic spine (HP:0100711) | 1.84566421 |
| 111 | Abnormality of eosinophils (HP:0001879) | 1.84336613 |
| 112 | Increased connective tissue (HP:0009025) | 1.82875899 |
| 113 | Gingivitis (HP:0000230) | 1.82430146 |
| 114 | Micronodular cirrhosis (HP:0001413) | 1.81991862 |
| 115 | Truncal obesity (HP:0001956) | 1.81483122 |
| 116 | Dysostosis multiplex (HP:0000943) | 1.81337514 |
| 117 | Periodontitis (HP:0000704) | 1.80790045 |
| 118 | Osteomyelitis (HP:0002754) | 1.80699649 |
| 119 | Lymphopenia (HP:0001888) | 1.80347262 |
| 120 | Sepsis (HP:0100806) | 1.79870493 |
| 121 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79766938 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79766938 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79766938 |
| 124 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79433365 |
| 125 | Osteolytic defects of the hand bones (HP:0009699) | 1.79433365 |
| 126 | Prolonged bleeding time (HP:0003010) | 1.76239170 |
| 127 | Dysmetric saccades (HP:0000641) | 1.75775117 |
| 128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.73740412 |
| 129 | Distal arthrogryposis (HP:0005684) | 1.71582365 |
| 130 | Thrombocytosis (HP:0001894) | 1.71413991 |
| 131 | Progressive muscle weakness (HP:0003323) | 1.70887790 |
| 132 | Abnormality of macrophages (HP:0004311) | 1.70809523 |
| 133 | Mucopolysacchariduria (HP:0008155) | 1.70595321 |
| 134 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.70595321 |
| 135 | Neck muscle weakness (HP:0000467) | 1.70579741 |
| 136 | Lip pit (HP:0100267) | 1.70421000 |
| 137 | Arterial tortuosity (HP:0005116) | 1.70175090 |
| 138 | Abnormality of T cell physiology (HP:0011840) | 1.69244349 |
| 139 | Bicuspid aortic valve (HP:0001647) | 1.67438813 |
| 140 | Obstructive sleep apnea (HP:0002870) | 1.67040467 |
| 141 | Termporal pattern (HP:0011008) | 1.65917279 |
| 142 | Insidious onset (HP:0003587) | 1.65917279 |
| 143 | Thoracolumbar scoliosis (HP:0002944) | 1.65829327 |
| 144 | Exocrine pancreatic insufficiency (HP:0001738) | 1.65717502 |
| 145 | Skin ulcer (HP:0200042) | 1.65583800 |
| 146 | Genu recurvatum (HP:0002816) | 1.65581387 |
| 147 | Prominent nose (HP:0000448) | 1.65425373 |
| 148 | Asymmetric septal hypertrophy (HP:0001670) | 1.65314067 |
| 149 | Hepatitis (HP:0012115) | 1.64155961 |
| 150 | Hyperacusis (HP:0010780) | 1.63268803 |
| 151 | Long palpebral fissure (HP:0000637) | 1.62856042 |
| 152 | Mitral regurgitation (HP:0001653) | 1.62809918 |
| 153 | Basal cell carcinoma (HP:0002671) | 1.62664891 |
| 154 | Acrocyanosis (HP:0001063) | 1.62410651 |
| 155 | Hyporeflexia of lower limbs (HP:0002600) | 1.61795475 |
| 156 | IgA deficiency (HP:0002720) | 1.61678878 |
| 157 | Absent frontal sinuses (HP:0002688) | 1.60272455 |
| 158 | Germ cell neoplasia (HP:0100728) | 1.60144114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.62305192 |
| 2 | PRPF4B | 3.92936922 |
| 3 | EEF2K | 3.76079387 |
| 4 | MAP3K10 | 3.58492350 |
| 5 | ERN1 | 3.22302990 |
| 6 | TRIB3 | 2.87116033 |
| 7 | TIE1 | 2.42061717 |
| 8 | EPHB1 | 2.27882007 |
| 9 | CDK12 | 2.22825354 |
| 10 | PKN2 | 2.22320212 |
| 11 | SMG1 | 2.03880215 |
| 12 | STK10 | 2.01745657 |
| 13 | CSF1R | 2.01250212 |
| 14 | JAK3 | 1.98743119 |
| 15 | FGFR4 | 1.88885844 |
| 16 | SIK1 | 1.88875322 |
| 17 | TYK2 | 1.87631595 |
| 18 | OBSCN | 1.73768875 |
| 19 | GRK6 | 1.70607333 |
| 20 | CDK6 | 1.67787585 |
| 21 | DMPK | 1.62575276 |
| 22 | TTN | 1.59738694 |
| 23 | ZAP70 | 1.58538497 |
| 24 | LRRK2 | 1.51054540 |
| 25 | PTK6 | 1.49519435 |
| 26 | TBK1 | 1.43109149 |
| 27 | HCK | 1.42202711 |
| 28 | ICK | 1.41784331 |
| 29 | MAP3K13 | 1.35459878 |
| 30 | RIPK1 | 1.35151574 |
| 31 | MAPK12 | 1.35035221 |
| 32 | JAK1 | 1.32910933 |
| 33 | ITK | 1.30406977 |
| 34 | PRKD3 | 1.28655839 |
| 35 | MAP3K14 | 1.28236322 |
| 36 | BMX | 1.25970800 |
| 37 | PIK3CG | 1.25968722 |
| 38 | NEK9 | 1.24764971 |
| 39 | CHUK | 1.22970274 |
| 40 | CLK1 | 1.22912033 |
| 41 | SIK2 | 1.21289491 |
| 42 | TAOK1 | 1.20841656 |
| 43 | TEC | 1.20520956 |
| 44 | CSK | 1.18921416 |
| 45 | IKBKB | 1.18449202 |
| 46 | EPHA3 | 1.14574270 |
| 47 | BLK | 1.13343067 |
| 48 | BTK | 1.13032828 |
| 49 | HIPK2 | 1.11307920 |
| 50 | BMPR2 | 1.08715996 |
| 51 | LCK | 1.08093805 |
| 52 | SYK | 1.05756009 |
| 53 | MARK2 | 1.04929260 |
| 54 | TGFBR2 | 1.03756338 |
| 55 | TXK | 1.03182225 |
| 56 | MAP3K2 | 1.03158288 |
| 57 | MARK3 | 1.02433545 |
| 58 | PASK | 1.01612353 |
| 59 | PDK2 | 1.00738254 |
| 60 | MTOR | 0.99266446 |
| 61 | PIM1 | 0.97655707 |
| 62 | STK3 | 0.97506666 |
| 63 | MAPK11 | 0.97495263 |
| 64 | IKBKE | 0.96460983 |
| 65 | SGK3 | 0.95579456 |
| 66 | AKT3 | 0.94035178 |
| 67 | MAP3K7 | 0.92910505 |
| 68 | PRKCH | 0.92526005 |
| 69 | NLK | 0.90414580 |
| 70 | IRAK4 | 0.88929467 |
| 71 | TAOK3 | 0.86852561 |
| 72 | FGFR3 | 0.86801999 |
| 73 | MAP3K11 | 0.85742077 |
| 74 | SGK2 | 0.85650078 |
| 75 | MAP2K3 | 0.84320592 |
| 76 | LMTK2 | 0.83542415 |
| 77 | ALK | 0.80734361 |
| 78 | NME2 | 0.78942238 |
| 79 | RPS6KA6 | 0.78915982 |
| 80 | JAK2 | 0.76962327 |
| 81 | RPS6KA4 | 0.76168854 |
| 82 | MAP3K3 | 0.75760520 |
| 83 | IRAK3 | 0.75281430 |
| 84 | RPS6KC1 | 0.73530693 |
| 85 | RPS6KL1 | 0.73530693 |
| 86 | BRD4 | 0.73436925 |
| 87 | CAMK1D | 0.71964668 |
| 88 | STK4 | 0.68213903 |
| 89 | PDPK1 | 0.67685221 |
| 90 | PRKD2 | 0.67183650 |
| 91 | PDGFRB | 0.67112670 |
| 92 | FES | 0.66740944 |
| 93 | EIF2AK3 | 0.66089033 |
| 94 | TRPM7 | 0.65084450 |
| 95 | MAP3K6 | 0.64201670 |
| 96 | MELK | 0.62855769 |
| 97 | NEK6 | 0.62236134 |
| 98 | MOS | 0.60806409 |
| 99 | STK11 | 0.60748864 |
| 100 | MST1R | 0.59554221 |
| 101 | RIPK4 | 0.57909868 |
| 102 | TYRO3 | 0.57211118 |
| 103 | CAMK1G | 0.56775593 |
| 104 | CDC42BPA | 0.55669234 |
| 105 | PDGFRA | 0.55578762 |
| 106 | MAPK4 | 0.55493108 |
| 107 | SIK3 | 0.54961656 |
| 108 | NUAK1 | 0.54392003 |
| 109 | RPS6KA2 | 0.53997051 |
| 110 | MAP3K1 | 0.52810830 |
| 111 | RPS6KA1 | 0.52782903 |
| 112 | PRKCQ | 0.51965223 |
| 113 | KIT | 0.51888600 |
| 114 | PAK2 | 0.51344683 |
| 115 | WNK1 | 0.50104089 |
| 116 | STK38 | 0.49531067 |
| 117 | CCNB1 | 0.47656943 |
| 118 | TAOK2 | 0.46725243 |
| 119 | MAPK7 | 0.46627699 |
| 120 | PTK2 | 0.46569606 |
| 121 | IRAK2 | 0.46124131 |
| 122 | CAMKK2 | 0.46028119 |
| 123 | CDK9 | 0.44249340 |
| 124 | RPS6KB1 | 0.43617705 |
| 125 | CDK4 | 0.43430716 |
| 126 | DYRK1B | 0.43383486 |
| 127 | YES1 | 0.43365065 |
| 128 | RPS6KA5 | 0.42662896 |
| 129 | MAP3K8 | 0.42525894 |
| 130 | PKN1 | 0.42481025 |
| 131 | MAPKAPK2 | 0.42083343 |
| 132 | PRKD1 | 0.41356506 |
| 133 | TNK2 | 0.41080486 |
| 134 | INSR | 0.39392167 |
| 135 | LYN | 0.39185775 |
| 136 | RET | 0.37919842 |
| 137 | MAP2K2 | 0.36638083 |
| 138 | SCYL2 | 0.36604648 |
| 139 | PDK1 | 0.36224189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.79975863 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.63321305 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.43811309 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21680408 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16065631 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.11769399 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07353572 |
| 8 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.03992500 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.02037418 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.90644005 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.75306839 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68548371 |
| 13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.57946573 |
| 14 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.50143888 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50095229 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49782514 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44767640 |
| 18 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.40741261 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39366513 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37388649 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36606257 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35406051 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32475252 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32165446 |
| 25 | Hepatitis B_Homo sapiens_hsa05161 | 1.31680868 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30186485 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28480657 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27685264 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.26491543 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.25648543 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.25520056 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25434675 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21619219 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21482220 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19852230 |
| 36 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19080742 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.16777419 |
| 38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.14987397 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.14599160 |
| 40 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.14573965 |
| 41 | Thyroid cancer_Homo sapiens_hsa05216 | 1.13271485 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12971667 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12848283 |
| 44 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.11442350 |
| 45 | HTLV-I infection_Homo sapiens_hsa05166 | 1.10511003 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09796463 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.08746872 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.08376484 |
| 49 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.07945372 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.06118900 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05958902 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05823266 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05135628 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 1.01550740 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99703961 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99340769 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.98637827 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96913192 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95070614 |
| 60 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94809561 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.94545267 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94502530 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93838963 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93427363 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92940215 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 0.92323218 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.90199200 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.90086832 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89458845 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.89362400 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 0.85315421 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.82474941 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82217640 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79823672 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79241366 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78705176 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76371751 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.75992786 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.75892695 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.75845586 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74416964 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74321515 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72061363 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71875793 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71813213 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70966022 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70591704 |
| 88 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69875726 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66709876 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66262939 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.66017617 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.65634860 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65227042 |
| 94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64620018 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64184398 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64135720 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63016945 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62742085 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61197402 |
| 100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60431707 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59878379 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59530096 |
| 103 | Glioma_Homo sapiens_hsa05214 | 0.58840413 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58809888 |
| 105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58337254 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57950988 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55669089 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55303613 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55035292 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.54214859 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54146062 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51470753 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47490016 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46705569 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44623037 |

